Cancer Treatment Reviews
Volume 27, Issue 6 , Pages 365-374 , December 2001

Rationale and techniques of intra-operative hyperthermic intraperitoneal chemotherapy

References 

  1. Weissberger AS, Levine B, Storaasli JP. Use of nitrogen mustard in treatment of serous effusions of neoplastic origin. JAMA. 1955;159:1704–1707
  2. Dedrick RL, Myers CE, Bungay PM, DeVita VT. Pharmacokinetic rationale for peritoneal drug administration in the treatment of ovarian cancer. Cancer Treat Rep. 1978;62:1–9
  3. Jones RB, Myers CE, Guarino AM. High volume intraperitoneal chemotherapy (“belly bath”) for ovarian cancer. Pharmacologic basis and early results. Cancer Chemother Pharmacol. 1978;1:161–166
  4. Howell SB, Zimm S, Markman M. Long-term survival of advanced refractory ovarian carcinoma patients with small-volume disease treated with intraperitoneal chemotherapy. J Clin Oncol. 1987;5:1607–1612
  5. Alberts DS, Liu PY, Hannigan EV. Intraperitoneal cisplatin plus intravenous cyclophosphamide versus intravenous cisplatin plus intravenous cyclophosphamide for stage III ovarian cancer. N Engl J Med. 1996;335:1950–1955
  6. Ozols RF, Gore M, Tropé C. Intraperitoneal treatment and dose-intense therapy in ovarian cancer. Ann Oncol. 1999;10:59–64
  7. Griffiths CT, Parker LM, Fuller AF. Role of cytoreductive surgical treatment in the management of advanced ovarian cancer. Cancer Treat Rep. 1979;63:235–240
  8. Eisenkop SM, Friedman RL, Wang HJ. Secondary cytoreductive surgery for recurrent ovarian cancer. A prospective study. Cancer. 1995;76:1606–1614
  9. Sugarbaker PH. Peritonectomy procedures. Ann Surg. 1995;221:29–42
  10. Sugarbaker PH, Ronnet B, Archer A. Pseudomyxoma peritonei syndrome. Adv Surg. 1996;30:233–280
  11. Christophi C, Winkworth A, Muralihdaran V, Evans P. The treatment of malignancy by hyperthermia. Surg Oncol. 1999;7:83–90
  12. Dahl O, Dalene R, Schem BC, Mella O. Status of clinical hyperthermia. Acta Oncol. 1999;38:863–873
  13. Storm FK. Clinical hyperthermia and chemotherapy. Radiol Clin N America. 1989;27:621–627
  14. Bull J MC. An update on the anticancer effects of a combination of chemotherapy and hyperthermia. Cancer Res. 1984;44:4853s–4856s
  15. Spratt JS, Adcock RA, Sherrill W, Travathen S. Hyperthermic peritoneal perfusion system in canines. Cancer Res. 1980;40:253–255
  16. Spratt JS, Adcock RA, Muskovin M. Clinical delivery system for intraperitoneal hyperthermic chemotherapy. Cancer Res. 1980;40:256–260
  17. Averbach AM, Sugarbaker PH. Methodologic considerations in treatment using intraperitoneal chemotherapy. Cancer Treat Res. 1996;82:289–309
  18. Sugarbaker PH. Management of peritoneal-surface malignancy: the surgeon's role. Langenbecks Arch Surg. 1999;384:576–587
  19. Fujimura T, Yonemura Y, Muraoka K. Continuous hyperthermic peritoneal perfusion for the prevention of peritoneal recurrence of gastric cancer: randomised controlled study. World J Surg. 1994;18:150–155
  20. Yonemura Y, Fujimura T, Fushida S. Hyperthermo-chemotherapy combined with cytoreductive surgery for the treatment of gastric cancer with peritoneal dissemination. World J Surg. 1991;15:530–536
  21. Elias D, Damia E, Puizillout J. Thermic homogeneity and standardization of intraperitoneal chemohyperthermia for peritoneal carcinomatosis. Reg Cancer Treat. 1996;9:54–59
  22. Fujimoto S, Shrestha R, Kokobun M. Intraperitoneal hyperthermic perfusion combined with surgery effective for gastric cancer patients with peritoneal seeding. Ann Surg. 1988;36–40
  23. Koga S, Hamazoe R, Maeta M. Prophylactic therapy for peritoneal recurrence of gastric cancer by continuous hyperthermic peritoneal perfusion with mitomycin-C. Cancer. 1988;61:232–237
  24. Tsiftis D, de Bree E, Romanos J. Peritoneal expansion by artificially produced ascites during perfusion chemotherapy. Arch Surg. 1999;134:545–549
  25. Jacquet P, Stuart OA, Chang D, Sugarbaker PH. Effects ofintra-abdominal pressure on pharmacokinetics and tissue distribution of doxorubicin after intraperitoneal administration. Anticancer Drugs. 1996;7:596–603
  26. Fernandez-Trigo V, Stuart OA, Stephens AD. Surgically directed chemotherapy: heated intraperitoneal lavage with mitomycin C. Cancer Treat Res. 1996;81:51–61
  27. Otani S, Maeta M, Oka A. Long term survival of 5 years following initial surgery for gastric cancer and simultaneous disseminated peritoneal metastasis. Surg Today. 1995;25:959–961
  28. Shido A, Ohmura S, Yamamoto K. Does hyperthermia induce peritoneal damage in continuous hyperthermic peritoneal perfusion. World J Surg. 2000;24:507–511
  29. Jacquet P, Sugarbaker PH. Peritoneal-plasma barrier. Cancer Treat Res. 1196;82:53–63
  30. Rubin J, Jones Q, Planch A, Bower JD. The minimal importance of hollow viscera to peritoneal transport during peritoneal dialysis in the rat. Am Soc Artif Intern Organs Transact. 1988;34:912–915
  31. Ceelen WP, Hesse U, de Hemptinne B, Pattyn P. Hyperthermic intraperitoneal chemoperfusion in the treatment of locally advanced intra-abdominal cancer. Br J Surg. 2000;87:1006–1015
  32. Fujimoto S, Shrestha RD, Kokobun M. Pharmacokinetic analysis of mitomycin C for intraperitoneal hyperthermic perfusion in patients with far-advanced or recurrent gastric cancer. Reg Cancer Treat. 1989;2:198–202
  33. Nicoletto MO, Padrini R, Galeotti F. Pharmacokinetics of intraperitoneal hyperthermic perfusion with mitoxantrone in ovarian cancer. Cancer Chemother Pharmacol. 2000;45:457–462
  34. Jacquet P, Averbach A, Stuart OA. Hyperthermic intraperitoneal doxorubicin: pharmacokinetics, metabolism, and tissue distribution in a rat model. Cancer Chemother Pharmacol. 1998;41:147–154
  35. Panteix G, Guillaumont M, Cherpin L. Study of the pharmakokinetics of mitomycin C in humans during intraperitoneal chemothermia with special mention of the concentration in local tissues. Oncology. 1993;50:366–370
  36. van de Vaart P JM, Van der Vange N, Zoetmulder F AN. Intraperitoneal cisplatin with regional hyperthermia in advanced ovarian cancer: pharmacokinetics and cisplatin-DNA adduct formation in patients and ovarian cancer cell lines. Eur J Cancer. 1998;34:148–154
  37. Ma GY, Bartlett DL, Reed E. Continuous hyperthermic peritoneal perfusion with cisplatin for the treatment of peritoneal mesothelioma. Cancer J Sci Am. 1997;3:174–176
  38. Loggie, B, W, Fleming, R, A, Complications of heated intraperitoneal chemotherapy and strategies for prevention, 1996, 221, 233
  39. Beaujard AC, Glehen O, Caillot JL. Intraperitoneal chemohyperthermia with mitomycin C for digestive tract cancer patients with peritoneal carcinomatosis. Cancer. 2000;88:2512–2519
  40. Los G, van Vucht MJ, Pinedo HM. Response of peritoneal solid tumors after i.p. chemohyperthermia treatment with cisplatin or carboplatin. Br J Cancer. 1994;69:235–241
  41. Wientjes MG, Badalament RA, Wang RC. Penetration of mitomycin C in human bladder. Cancer Res. 1993;53:3314
  42. Jacquet P, Averbach A, Stephens AD. Heated intraoperative intraperitoneal mitomycin C and early postoperative intraperitoneal 5-fluorouracil: pharmacokinetic studies. Oncology. 1998;55:130–138
  43. Witkamp AJ, de Bree E, Kaag MM. Extensive surgical cytoreduction and intra-operative hyperthermic intraperitoneal chemotherapy in patients with pseudomyxoma peritonei. Br J Surg. 2001;88:458–463
  44. Cavaliere F, Di Filippo F, Botti C. Peritonectomy and hyperthermic antiblast perfusion in the treatment of peritoneal carcinomatosis. Eur J Surg Onc. 2000;26:486–491
  45. Steller MA, Egorin MJ, Trimble EL. A pilot phase I trial of continuous hyperthermic peritoneal perfusion with high-dose carboplatin as primary treatment of patients with small-volume residual ovarian cancer. Cancer Chemother Pharmacol. 1999;43:106–114
  46. Jacquet P, Stephens AD, Averbach AM, Chang D, Ettinghausen SE, Dalton RR, et al. Analysis of morbidity and mortality in 60 patients with peritoneal carcinomatosis treated by cytoreductive surgery and heated intraoperative intraperitoneal chemotherapy. Cancer. 1996;77:2622–2629
  47. Ikeguchi M, Kondou A, Oka A. Effects of continuous hyperthermic peritoneal perfusion on prognosis of gastric cancer with serosal invasion. Eur J Surg. 1995;161:581–586
  48. Yonemura Y, Ninomiya I, Kaji M. Prophylaxix with intraoperative chemohyperthermia against peritoneal recurrence of serosal invasion-positive gastric cancer. World J Surg. 1995;19:450–455
  49. Stephens AD, Alderman R, Chang D. Morbidity and mortality analysis of 200 treatments with cytoreductive surgery and hyperthermic intraoperative intraperitoneal chemotherapy using the coliseum technique. Ann Surg Oncol. 1999;6:790–796
  50. Witkamp AJ, de Bree E, Kaag MM. Extensive cytoreductive surgery followed by intra-operative hyperthermic intraperitoneal chemotherapy with mitomycin-C in patients with peritoneal carcinomatosis from colorectal origin. Eur J Cancer. 2001;
  51. Fumagalli U, Trabucchi E, Soligo M. Effects of intraperitoneal chemotherapy on anastomotic healing in the rat. J Surg Res. 1991;50:82–87
  52. Hamazoe R, Maeta M, Kaibara N. Intraperitoneal thermochemotherapy for prevention of peritoneal recurrence of gastric cancer. Final results of a randomised controlled study. Cancer. 1994;73:2048–2052
  53. Fujimoto S, Shrestha R, Kokobun M. Positive results of combined therapy of surgery and intraperitoneal hyperthermic perfusion for far-advanced gastric cancer. Ann Surg. 1990;212:592–596
  54. Sayag-Beuajard AC, Francois Y, Glehen O. Intraperitoneal chemohyperthermia with mitomycin C for gastric cancer patients with peritoneal carcinomatosis. Anticancer Res. 1999;19:1375–1382
  55. Witkamp AJ, Muller SH, de Bree E. Impact of mitomycin-C kinetics on surgical complications after hyperthermic intraperitoneal chemotherapy (HIPEC). Eur J Surg Oncol. 2000;26:
  56. Loggie BW, Fleming RA. Complications of heated intraperitoneal chemotherapy and strategies for prevention. Cancer Treat Res. 1996;82:221–233
  57. Özgüroglu M, Demir G, Demirelli F, Mandel NM. Anaphylaxis from intraperitoneal infusion of cisplatin: a case report. Am J Clin Oncol. 1999;22:172–173
  58. de Bree E, Christodoulakis M, Tsiftis D. Malignant peritoneal mesothelioma treated by continuous hyperthermic peritoneal perfusion chemotherapy. Ann Oncol. 2000;
  59. Eilber FC, Rosen G, Forscher C. Surgical resection and intraperitoneal chemotherapy for recurrent abdominal sarcomas. Ann Surg Oncol. 1999;6:645–650
  60. Van der Vange N, van Goethem AR, Zoetmulder F AN. Extensive cytoreductive surgery combined with intra-operative intraperitoneal perfusion with cisplatin under hyperthermic conditions (OVHIPEC) in patients with recurrent ovarian cancer: a pilot study. Eur J Surg Onc. 2000;
  61. Fujimoto S, Takahashi M, Mutou T. Improved mortality rate of gastric carcinoma patients with peritoneal carcinomatosis treated with intraperitoneal hyperthermic chemoperfusion combined with surgery. Cancer. 1997;79:884–891
  62. Yu W, Whang I, Suh I. Prospective randomised trial of early postoperative intraperitoneal chemotherapy as an adjuvant to resectable gastric cancer. Ann Surg. 1998;228:347–354
  63. Fujimoto S, Takahashi M, Mutou T. Successful intraperitoneal hyperthermic chemoperfusion for the prevention of postoperative peritoneal recurrence in patients with advanced gastric carcinoma. Cancer. 1999;85:529–534
  64. Schneebaum S, Arnold MW, Staubus A. Intraperitoneal hyperthermic perfusion with mitomycin C for colorectal cancer with peritoneal metastases. Ann Surg Oncol. 1996;3:44–50
  65. Sugarbaker PH, Chang D. Results of treatment of 385 patients with peritoneal surface spread of appendiceal malignancy. Ann Surg Oncol. 1999;6:727–731
  66. Cavaliere F, Perri P, Di Filippo F. Treatment of peritoneal carcinomatosis with intent to cure. J Surg Oncol. 2000;74:41–44
  67. Elias D, Dubé P, Blot F. Peritoneal carcinomatosis treatment with curative intent: the Institut Gustave-Roussy experience. Eur J Surg Onc. 1997;23:317–321
  68. Loggie BW, Fleming RA, McQuellen RP. Cytoreductive surgery with intraperitoneal hyperthermic chemotherapy for disseminated peritoneal cancer of gastrointestinal origin. Am Surgeon. 2000;66:561–568
  69. Rietbroek, R, C, Hyperthermia in combination with chemotherapy: from laboratory bench to bedside, 1996, 13, 37
  70. Stephens AD, Belliveau JF, Sugarbaker PH. Intraoperative hyperthermic lavage with cisplatin for peritoneal carcinomatosis and sarcomatosis. Cancer Treat Res. 1996;81:15–30
  71. Yonemura Y, Fujimura T, Nishimura G. Effects of intraoperative chemohyperthermia in patients with gastric cancer with peritoneal dissemination. Surgery. 1996;119:437–444

PII: S0305-7372(01)90232-4

doi: 10.1053/ctrv.2001.0232

Cancer Treatment Reviews
Volume 27, Issue 6 , Pages 365-374 , December 2001

Article Tools